Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

nabilone/cáncer

El enlace se guarda en el portapapeles.
Página 1 desde 73 resultados

Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Nabilone, a synthetic cannabinoid, and Prochlorperazine were compared in a double-blind crossover study of 34 patients with lung cancer undergoing a 3-day schedule of chemotherapy with Cyclophosphamide, Adriamycin and Etoposide. Symptom scores were significantly better for patients on nabilone for

A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
An anti-emetic drug, nabilone, a synthetic cannabinoid, has been compared with prochlorperazine in 24 lung cancer patients receiving cancer chemotherapy. Each of the drugs studied was given orally every 12 hours, starting the night before chemotherapy, during one of two consecutive identical

[Randomized comparative trial of a new anti-emetic: nabilone, in cancer patients treated with cisplatin].

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
A randomized, double-blind controlled trial of nabilone versus chlorpromazine was performed in 20 patients with advanced gynaecological cancer who received chemotherapy including cis-platinum. Each patient served as his own control. Nabilone was administered at a dose of 3 mg given orally three
Twenty nonseminomatous testicular cancer patients not pretreated with emetogenic chemotherapy were included in a crossover study of antiemetic therapy. Patients were randomly assigned to receive either nabilone (2 X 2 mg/day) or alizapride (3 X 150 mg/day) prior to beginning low-dose cisplatin

Antiemetic efficacy of nabilone and dexamethasone: a randomized study of patients with lung cancer receiving chemotherapy.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
In a previous study on the antiemetic effect of nabilone (N) in patients with lung cancer receiving chemotherapy (CT), we found that N was only moderately effective and that its side effects limited its use, especially in elderly outpatients. We, therefore, performed a new study of N in combination
BACKGROUND Over one half of the patients diagnosed with advanced lung cancer experience anorexia. In addition to its high incidence, cancer-induced anorexia promotes the development of the anorexia-cachexia syndrome, which is related to poor clinical outcomes. Recently, drugs derived from

Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
A prospective observational study assessed the effectiveness of adjuvant nabilone (Cesamet) therapy in managing pain and symptoms experienced by advanced cancer patients. The primary outcomes were the differences between treated and untreated patients at 30 days' follow-up, in Edmonton Symptom

Nabilone versus prochlorperazine for control of cancer chemotherapy-induced emesis in children: a double-blind, crossover trial.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
In a randomized, double-blind, crossover trial, nabilone was compared to prochlorperazine for control of cancer chemotherapy-induced emesis in 30 children 3.5 to 17.8 years of age. All subjects received two consecutive identical cycles of chemotherapy with the trial antiemetics given in accordance

Nabilone: an effective antiemetic in patients receiving cancer chemotherapy.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Eighty evaluable patients receiving chemotherapy were entered on a random prospective double-blind study to evaluate the effectiveness of nabilone, a synthetic cannabinoid, compared to prochlorperazine. Most of these patients received cisplatin, a drug that universally produces severe nausea and

Superiority of nabilone over prochlorperazine as an antiemetic in patients receiving cancer chemotherapy.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Two double-blind, crossover trials comparing the antiemetic effectiveness of nabilone, a new synthetic cannabinoid, with that of prochlorperazine were conducted in patients with severe nausea and vomiting associated with anticancer chemotherapy. Of 113 patients evaluated, 90 (80 per cent) responded

Nabilone: an alternative antiemetic for cancer chemotherapy.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
A prospective randomised double blind crossover trial was conducted comparing the new synthetic cannabinoid nabilone with oral domperidone in a group of children receiving repeated identical courses of emetogenic chemotherapy for a variety of malignant diseases. Eighteen of 23 consecutive eligible

Nabilone and other antiemetics for cancer patients.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse

Nabilone: an effective antiemetic agent in patients receiving cancer chemotherapy.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse

Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse

Suppression of cancer chemotherapy-induced vomiting in the cat by nabilone, a synthetic cannabinoid.

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
Únete a nuestra
página de facebook

La base de datos de hierbas medicinales más completa respaldada por la ciencia

  • Funciona en 55 idiomas
  • Curas a base de hierbas respaldadas por la ciencia
  • Reconocimiento de hierbas por imagen
  • Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
  • Leer publicaciones científicas relacionadas con su búsqueda
  • Buscar hierbas medicinales por sus efectos.
  • Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.

Google Play badgeApp Store badge